
Groundbreaking clinical study demonstrates predictive value of PD-1/PD-L1 engagement measured by QF-Pro® even in PD-L1–negative NSCLC patients
HAWK Biosystems is proud to announce that Dr. Enrique Caballé-Pérez, from the Instituto Nacional de Cancerología (INCan, Mexico), will present a poster at the SITC 2025 Annual Meeting featuring







